 | Up a level |
Williams, Scott, Raheim, Siddig Abdel, Khan, Muhammad Ilyas, Rubab, Umme, Kanagala, Prathap, Zhao, Sizheng Steven, Marshall, Anne, Brown, Emily and Alam, Uazman 
ORCID: 0000-0002-3190-1122
(2022)
Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management.
CLINICAL THERAPEUTICS, 44 (10).
pp. 1394-1416.
Brown, Emily, Hydes, T ORCID: 0000-0002-7768-6886, Hamid, A and Cuthbertson, DJ ORCID: 0000-0002-6128-0822
(2021)
Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease.
CLINICAL THERAPEUTICS, 43 (9).
pp. 1476-1504.
Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822, Koskinen, Juha, Brown, Emily, Magnussen, Costan G, Hutri-Kahonen, Nina, Sabin, Matthew, Tossavainen, Paivi, Jokinen, Eero, Laitinen, Tomi, Viikari, Jorma et al (show 2 more authors)
(2021)
Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
ANNALS OF MEDICINE, 53 (1).
pp. 1256-1264.
Waddell, Tom, Bagur, Alexandre, Cunha, Diogo, Thomaides-Brears, Helena, Banerjee, Rajarshi, Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822, Brown, Emily, Cusi, Kenneth, Despres, Jean-Pierre and Brady, Michael
(2022)
Greater ectopic fat deposition and liver fibroinflammation, and lower skeletal muscle mass in people with type 2 diabetes.
OBESITY, 30 (6).
pp. 1231-1238.
Al-Bazz, Dalal Y, Nelson, Andrew J ORCID: 0000-0001-7430-9543, Burgess, Jamie ORCID: 0000-0002-7165-6918, Petropoulos, Ioannis N, Nizza, Jael, Marshall, Anne, Brown, Emily, Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822, Marshall, Andrew G ORCID: 0000-0001-8273-7089, Malik, Rayaz A et al (show 1 more authors)
(2022)
Is Nerve Electrophysiology a Robust Primary Endpoint in Clinical Trials of Treatments for Diabetic Peripheral Neuropathy?
DIAGNOSTICS, 12 (3).
731-.
Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822, Brown, Emily, Koskinen, Juha, Magnussen, Costan G, Hutri-Kahonen, Nina, Sabin, Matthew, Tossavainen, Paeivi, Jokinen, Eero, Laitinen, Tomi, Viikari, Jorma et al (show 2 more authors)
(2019)
Longitudinal analysis of risk of non-alcoholic fatty liver disease in adulthood.
LIVER INTERNATIONAL, 39 (6).
pp. 1147-1154.
Brown, Emily, Watkin, Daniel, Evans, Jonathan, Yip, Vincent and Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822
(2018)
Multidisciplinary management of refractory insulinomas.
CLINICAL ENDOCRINOLOGY, 88 (5).
pp. 615-624.
Brown, Emily, Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822 and Wilding, John P ORCID: 0000-0003-2839-8404
(2018)
Newer GLP-1 receptor agonists and obesity-diabetes.
PEPTIDES, 100.
pp. 61-67.
Rajeev, Surya, Roberts, Carl ORCID: 0000-0003-4275-601X, Brown, Emily, Sprung, Victoria ORCID: 0000-0002-2666-4986, Harrold, Jo ORCID: 0000-0002-0899-4586, Halford, Jason ORCID: 0000-0003-1629-3189, Stancak, Andrej ORCID: 0000-0003-3323-3305, Boyland, Emma ORCID: 0000-0001-8384-4994, Kemp, Graham ORCID: 0000-0002-8324-9666, Perry, Julie et al (show 4 more authors)
(2023)
No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled, cross-over trial (ENERGIZE).
Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics, 25 (12).
pp. 3621-3631.
Kirthi, Varo, Perumbalath, Anugraha, Brown, Emily, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Petropoulos, Ioannis N, Burgess, Jamie ORCID: 0000-0002-7165-6918, Roylance, Rebecca, Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822, Jackson, Timothy L, Malik, Rayaz A et al (show 1 more authors)
(2021)
Prevalence of peripheral neuropathy in pre-diabetes: a systematic review.
BMJ OPEN DIABETES RESEARCH & CARE, 9 (1).
e002040-.
Brown, Emily, Heerspink, Hiddo JL, Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822 and Wilding, John PH ORCID: 0000-0003-2839-8404
(2021)
SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications.
LANCET, 398 (10296).
pp. 262-276.
Brown, Emily, Wilding, John PH ORCID: 0000-0003-2839-8404, Barber, Thomas M, Alam, Uazman ORCID: 0000-0002-3190-1122 and Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822
(2019)
Weight loss variability with SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities.
OBESITY REVIEWS, 20 (6).
pp. 816-828.
Brown, Emily, Wilding, John PH ORCID: 0000-0003-2839-8404, Alam, Uazman ORCID: 0000-0002-3190-1122, Barber, Thomas M, Karalliedde, Janaka and Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822
(2021)
The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection.
ANNALS OF MEDICINE, 53 (1).
pp. 2072-2089.
Eleftheriadou, Aikaterini, Williams, Scott, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Brown, Emily, Roylance, Rebecca, Wilding, John PH ORCID: 0000-0003-2839-8404, Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822 and Alam, Uazman ORCID: 0000-0002-3190-1122
(2021)
The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review.
DIABETOLOGIA, 64 (2).
pp. 288-303.
Brown, Emily, Wilton, Moon M ORCID: 0000-0003-4052-7918, Sprung, Victoria S ORCID: 0000-0002-2666-4986, Harrold, Joanne A ORCID: 0000-0002-0899-4586, Halford, Jason CG ORCID: 0000-0003-1629-3189, Stancak, Andrej ORCID: 0000-0003-3323-3305, Burgess, Malcolm, Howarth, Elaine, Umpleby, A Margot, Kemp, Graham J ORCID: 0000-0002-8324-9666 et al (show 2 more authors)
(2021)
A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol.
BMJ open, 11 (7).
e045663-e045663.
Brown, Emily, Rajeev, Surya P, Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822 and Wilding, John PH ORCID: 0000-0003-2839-8404
(2019)
A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium-glucose co-transporter-2 inhibitors.
DIABETES OBESITY & METABOLISM, 21.
9 - 18.